BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2009
View Archived Issues
Merck Frosst describes cysteine protease inhibitors for the treatment of parasitic infections
Read More
Novel histamine H3 receptor ligands revealed in recent Janssen patents
Read More
Wyeth discovers novel PDE10 inhibitors for the treatment of psychosis, mood disorders, etc.
Read More
Further phase II data on IMC-11F8 plus mFOLFOX-6 in advanced colorectal cancer reported
Read More
Medicago reports results from immunogenicity study in mice of its swine flu vaccine
Read More
CytRx files response to partial FDA clinical hold on phase IIb arimoclomol trial
Read More
Pregabalin effective in first controlled study in restless legs syndrome
Read More
Sucampo announces results from phase II trial of cobiprostone in patients treated with NSAIDs
Read More
Shire's Vyvanse demonstrates efficacy in a phase IIIb study in adults with ADHD
Read More
Bionomics updates clinical progress of BNC-105 and BCN-210
Read More
Graceway acquires early-stage dermatological compounds from Pfizer
Read More
Cardioxyl commences phase I/IIa study for CXL-1020 in heart failure
Read More
FDA issues complete response letter regarding Acura's and King's NDA for Acurox
Read More
Oncolytics completes enrollment in phase I/II trial of Reolysin in head and neck cancer
Read More
Johnson & Johnson acquires Elan's Alzheimer's immunotherapy program
Read More
Myriad Pharmaceuticals completes spin-off from Myriad Genetics
Read More
Eisai updates Aricept's development programs of new indications and formulations
Read More
Asthmatic responses reduced with eculizumab in allergic asthmatics
Read More
TRPA1 antagonist HC-030031 alleviates experimental allergic asthma
Read More
Phase III data show significant effects of DX-88 on hereditary angioedema attacks
Read More
Tekmira initiates phase I human clinical trial of ApoB SNALP for LDL cholesterol
Read More
European Commission grants marketing authorization for Novo Nordisk's Victoza
Read More
FDA grants approval to Clavis to include U.S. patients in phase II clinical trial of CP-4126
Read More
Rosiglitazone combination therapy increases the risk of heart failure but not CV mortality
Read More
Lundbeck reports results from dose-finding clinical trial of Lu-AA-24530 in MDD
Read More